 |
| U.S. Medical Foods Market |
Market Overview:
The U.S. medical foods market comprises specialty formulated food products that
are intended for the dietary management of diseases or health conditions under
medical supervision. Medical foods aim to fulfill distinctive nutritional
requirements for a disease or disorder when conventional foods alone cannot.
Some common examples include food products designed to manage inherited metabolic
disorders, HIV/AIDS wasting, diabetes, depression, Alzheimer’s disease, and
pulmonary diseases. There has been a rise in the prevalence of chronic
metabolic disorders such as diabetes and obesity among the U.S. population in
recent years. Medical foods provide a useful dietary option to manage the
nutritional needs associated with these conditions. The market offers
customized food products that resemble conventional foods and serve as a more
palatable alternative to dietary supplements.
The U.S. Medical
Foods Market is estimated to be valued at US$
25722.45 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2030.
Key Takeaways:
Key players operating in the U.S. medical foods are Magellan, Medipost Co.,
Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals
Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell
Technologies, Inc. These leaders are focusing on new product launches and
acquisitions to strengthen their market position. For instance, in 2022,
Magellan Health acquired Med Allies grocery delivery service to expand its
medical foods delivery platform.
There is high demand for customized medical nutrition products that cater to
the specific needs of individuals. Manufacturers are investing in personalized
formulations and precision nutrition approaches using ingredients like
prebiotics, probiotics, and microbiome-targeted therapies. The growing
geriatric population and proliferating chronic disease prevalence also present
opportunities for new clinical indications and partnerships with healthcare
providers.
The medical foods market has gained significant traction in the US but players
are also exploring opportunities in global regions. Favorable regulatory
systems and reimbursement policies and the increasing incidence of metabolic
disorders in countries like China, Japan and Australia due to lifestyle changes
are encouraging companies to expand their international footprint.
Partnerships, joint ventures and acquisitions remain key strategies for
overseas market penetration.
Market Drivers:
The key driver for the U.S. medical food market is the increasing prevalence of
metabolic disorders. According to CDC reports, nearly 40% of the US adult
population is clinically obese and over 34 million Americans have diabetes.
Medical foods support the dietary management of these conditions. Moreover,
rising healthcare costs have amplified demand for lower cost alternatives like
medical nutrition to mainstream clinical care. Publications demonstrating the
healthcare cost savings and effectiveness of specialty formulated foods in
chronic disease management further support market growth.
Market Restrains:
A major challenge is the limited awareness about medical foods among healthcare
professionals and consumers. Many view them as substitutes for pharmacological
interventions. Moreover, not all medical food products are eligible for
insurance coverage or reimbursement which constrain their uptake. Formulation
complexities and stringent regulatory clearances associated with proprietary
ingredient formulations also increase the barriers for new entrants. High
R&D costs needed to demonstrate efficacies as per FDA guidelines pose
another challenge for market players.
Segment Analysis
The U.S.Medical
Foods Market Demand is dominated
by the therapeutic foods and beverages segment which accounts for over 60% of
the market share. This is because most of the medical foods that are prescribed
target conditions like pulmonary disorders, gastrointestinal diseases, dental
disease, inborn errors of metabolism, and attention deficit hyperactivity
disorder, all of which can be effectively managed through specially formulated
drinks and food supplements. The ease of consumption of therapeutic foods and
beverages makes it a preferred choice over other segments like pills or
capsules.
Global Analysis
The North American region holds the largest share in the global medical foods
market due to superior healthcare infrastructure and availability of advanced
treatment options. Within North America, the United States dominates and
accounts for over 85% of the regional market share. This is because of presence
of major players, strong distribution network of medical foods and rising
prevalence of chronic and genetic diseases. The Asia Pacific region is poised
to grow at the fastest rate during the forecast period owing to growing medical
tourism, rising healthcare spending and increasing awareness about
nutrition-based disease management in countries like China, India and South
Korea.
For more insights, read- U.S.
Medical Foods Market
Check more trending articles related to this topic: Global
Panic Attack Treatment Market
0 Comments